Aoxing Pharmaceutical Company Inc.
AXN
AXN was delisted on the 16th of October, 2017.
0 hedge funds and large institutions have $0 invested in Aoxing Pharmaceutical Company Inc. in 2017 Q4 according to their latest regulatory filings, with 0 funds opening new positions, increasing their positions, 0 reducing their positions, and 8 closing their positions.
100% less funds holding
Funds holding: 8 → 0 (-8)
100% less capital invested
Capital invested by funds: $53K → $0 (-$53K)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 8
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VF
Virtu Financial
New York
|
-$22K |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$10K |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$7K |
| 4 |
Barclays
London,
United Kingdom
|
-$4K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$4K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
VF
1
Virtu Financial
New York
| – | -$22K | -138,411 | Closed |
|
|
2
Citadel Advisors
Miami,
Florida
| – | -$10K | -61,329 | Closed |
|
|
3
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| – | -$7K | -44,083 | Closed |
|
|
4
Barclays
London,
United Kingdom
| – | -$4K | -25,000 | Closed |
|
|
5
UBS Group
Zurich,
Switzerland
| – | -$4K | -22,423 | Closed |
|
|
TSS
6
Two Sigma Securities
New York
| – | -$3K | -17,777 | Closed |
|
|
EWM
7
Evercore Wealth Management
New York
| – | -$2K | -13,158 | Closed |
|
|
LTFS
8
Ladenburg Thalmann Financial Services
Miami,
Florida
| – | -$1K | -3,900 | Closed |
|
AXN Hedge Fund Activity: Q4 2017 in Review
0 of the 4,409 institutional investors tracked by Wall St. Rank reported a position in Aoxing Pharmaceutical Company Inc. (AXN) for Q4 2017, worth a combined $0 — down 100% from $53K a quarter earlier.
Sellers outnumbered buyers: 8 funds closed out of AXN and 0 opened new positions — a net loss of 8 holders — while 0 trimmed existing stakes and 0 added.
The largest seller was Virtu Financial, exiting entirely with an estimated $22K sold.
- 0 institutional investors held Aoxing Pharmaceutical Company Inc. (AXN) as of Q4 2017, down from 8 in Q3 2017.
- Funds reported $0 of Aoxing Pharmaceutical Company Inc. stock for Q4 2017, down 100% quarter-over-quarter.
- 0 funds opened new Aoxing Pharmaceutical Company Inc. positions in Q4 2017 and 8 closed out, a net change of -8 holders.
- The largest Aoxing Pharmaceutical Company Inc. seller in Q4 2017 was Virtu Financial, an estimated $22K sold.
Based on aggregated 13F filings for Q4 2017.